BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 36277689)

  • 21. Ketoconazole treatment in Cushing's syndrome: experience in 34 patients.
    Sonino N; Boscaro M; Paoletta A; Mantero F; Ziliotto D
    Clin Endocrinol (Oxf); 1991 Oct; 35(4):347-52. PubMed ID: 1752063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different therapeutic efficacy of ketoconazole in patients with Cushing's syndrome.
    Engelhardt D; Jacob K; Doerr HG
    Klin Wochenschr; 1989 Feb; 67(4):241-7. PubMed ID: 2538676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
    Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Classic and recent etiologies of Cushing's syndrome: diagnosis and therapy.
    Beauregard C; Dickstein G; Lacroix A
    Treat Endocrinol; 2002; 1(2):79-94. PubMed ID: 15765624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeat transsphenoidal surgery for Cushing's disease.
    Friedman RB; Oldfield EH; Nieman LK; Chrousos GP; Doppman JL; Cutler GB; Loriaux DL
    J Neurosurg; 1989 Oct; 71(4):520-7. PubMed ID: 2552045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adrenocorticotrophic hormone (ACTH) responsiveness to ghrelin increases after 6 months of ketoconazole use in patients with Cushing's disease: comparison with GH-releasing peptide-6 (GHRP-6).
    Correa-Silva SR; Nascif SO; Molica P; Sá LB; Vieira JG; Lengyel AM
    Clin Endocrinol (Oxf); 2010 Jan; 72(1):70-5. PubMed ID: 19453623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged treatment of Cushing's disease by ketoconazole.
    Sonino N; Boscaro M; Merola G; Mantero F
    J Clin Endocrinol Metab; 1985 Oct; 61(4):718-22. PubMed ID: 4031015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of the treatment of Cushing's syndrome using ketoconazole].
    Conget JI; Halperin I; Vendrell J; Ferrer J; Martínez-Osaba MJ; Esmatjes E; Vilardell E
    Med Clin (Barc); 1989 Nov; 93(14):531-4. PubMed ID: 2695699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.
    Mayberg M; Reintjes S; Patel A; Moloney K; Mercado J; Carlson A; Scanlan J; Broyles F
    J Neurosurg; 2018 Nov; 129(5):1268-1277. PubMed ID: 29271716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early repeat surgery for persistent Cushing's disease.
    Ram Z; Nieman LK; Cutler GB; Chrousos GP; Doppman JL; Oldfield EH
    J Neurosurg; 1994 Jan; 80(1):37-45. PubMed ID: 8271020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cabergoline treatment for recurrent Cushing's disease during pregnancy.
    Nakhleh A; Saiegh L; Reut M; Ahmad MS; Pearl IW; Shechner C
    Hormones (Athens); 2016 Jul; 15(3):453-458. PubMed ID: 27394707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low immediate postoperative serum-cortisol nadir predicts the short-term, but not long-term, remission after pituitary surgery for Cushing's disease.
    Ramm-Pettersen J; Halvorsen H; Evang JA; Rønning P; Hol PK; Bollerslev J; Berg-Johnsen J; Helseth E
    BMC Endocr Disord; 2015 Oct; 15():62. PubMed ID: 26499317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Utility of Osilodrostat in Cushing's Disease: Review of Currently Available Literature.
    Perosevic M; Tritos NA
    Drug Des Devel Ther; 2023; 17():1303-1312. PubMed ID: 37143705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome?
    Chee GH; Mathias DB; James RA; Kendall-Taylor P
    Clin Endocrinol (Oxf); 2001 May; 54(5):617-26. PubMed ID: 11380492
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful outcome of pregnancy in a patient with Cushing's disease under treatment with ketoconazole during the first trimester of gestation.
    Boronat M; Marrero D; López-Plasencia Y; Barber M; Schamann Y; Nóvoa FJ
    Gynecol Endocrinol; 2011 Sep; 27(9):675-7. PubMed ID: 20923280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discontinuation of Drug Treatment in Cushing's Disease Not Cured by Pituitary Surgery.
    Ghalawinji A; Drezet L; Chaffanjon P; Muller M; Sturm N; Simiand A; Lazard A; Gay E; Chabre O; Cristante J
    J Clin Endocrinol Metab; 2024 Mar; 109(4):1000-1011. PubMed ID: 37962981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy and long-term tolerance of ketoconazole in the treatment of Cushing's disease].
    Tabarin A; Navarranne A; Corcuff B; Guerin J; Kern AM; Roger P
    Ann Endocrinol (Paris); 1990; 51(1):27-32. PubMed ID: 2171415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cushing's disease: role of preoperative and primary medical therapy.
    Castinetti F
    Pituitary; 2022 Oct; 25(5):737-739. PubMed ID: 35780261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of hypercortisolism control on high blood pressure in Cushing's syndrome.
    Gómez RM; Albiger NM; Díaz AG; Moncet D; Pitoia FA; Bruno OD
    Medicina (B Aires); 2007; 67(5):439-44. PubMed ID: 18051226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the outcomes of the treatment of Cushing's disease in the hospitals of Castilla-La Mancha.
    Huguet I; Aguirre M; Vicente A; Alramadan M; Quiroga I; Silva J; Lamas C
    Endocrinol Nutr; 2015 May; 62(5):217-23. PubMed ID: 25842035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.